Exosomes

Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Microfluidics

How Microfluidic Devices are Benefitting Biopharmaceutical Development and Manufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cell-Free

Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Synthetic DNA

Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Genomics

Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Molecular Machines

The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Morpholinos

Modifying RNA Splicing with Morpholinos

Jon Moulton, Ph.D.

Gene Tools

Cell and Gene Therapy

View from the Top: Cell and Gene Therapy Successes and Promise

David Alvaro, Ph.D.

Pharma's Almanac

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

Column: Supply Chain

Reimagining the Pharmaceutical Supply Chain

Danielle Alvarez

Pharma's Almanac

Accelerating Inclusive Growth in St. Louis

Cortex Innovation Community

Pharma's Almanac

The Evolution and the Future of Pharma

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Feature Story

The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Feature Story

The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Feature Story

Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Gene Therapy

Gene Therapy R&D Accelerates

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

Year in Review

Pharma’s Almanac Most Impactful Thought Leadership of 2018

Nice Insight